Raloxifene

Category: Osteoporosis



Raloxifene Overview

Raloxifene, developed by Eli Lilly in 1997 and sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.[3][4][5] It is taken by mouth.[3] Side effects of raloxifene include hot flashes, leg cramps, and an increased risk of b...

Read more Raloxifene Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Raloxifene

Recent Raloxifene Forums: RSS Feed

lilly 4165

little white oval tablet with lilly 4165 printed on it. ## found it in my home would like to know the purpose of it is ## I, too, found a Lilly 4165 in my office. What is it? ## found drug in bathroom at work what is it for ## Raloxifen - 60mg, usually used to treat breast cancer, it blocks the effects of estrogen on breast tissue and/or other tissues with estrogen receptors. Belongs to a group of drugs called SERMs; Select Estrogen Receptor Modulators. But by modulate they really mean it antagonizes the receptor site. ## That is correct, this is 60mgs of Raloxifene, a generic for Evista. It does have other uses, though, one of which is to help prevent Osteoperosis. Some of the most common side effects include: nausea, hot flashes, leg cramps and blood clots. You can read more about thi...

Updated

Possible Dosages for this and Related Drugs:

Raloxifene
  • Tablet: 60mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Raloxifene: (28 results)

Showing the first 20, Sorted by National Drug Code
  • 0093-7290 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA Inc
  • 0179-0151 Raloxifene Hydrochloride 60 mg Oral Tablet by Kaiser Foundation Hospitals
  • 0179-0212 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Kaiser Foundation Hospitals
  • 0179-0220 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Kaiser Foundation Hospitals
  • 0440-5295 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Liberty Pharmaceuticals, Inc.
  • 0591-2367 Raloxifene 60 mg Oral Tablet, Film Coated by Actavis Pharma, Inc.
  • 31722-256 Raloxifene Hydrochloride 60 mg Oral Tablet by Camber Pharmaceuticals Inc
  • 42291-726 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Avkare, Inc.
  • 43353-253 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Aphena Pharma Solutions - Tennessee, LLC
  • 43598-505 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Dr.reddy’s Laboratories Inc
  • 50090-3866 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 50228-306 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Sciegen Pharmaceuticals Inc
  • 50268-694 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Avpak
  • 52343-137 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Lucid Pharma LLC
  • 60687-266 Raloxifene Hydrochloride 60 mg Oral Tablet by American Health Packaging
  • 63629-7708 Raloxifene Hydrochloride 60 mg Oral Tablet by Bryant Ranch Prepack
  • 65162-057 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals of New York, LLC
  • 65862-709 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Aurobindo Pharma Limited
  • 66993-417 Raloxifene Hydrochloride 60 mg/1 Oral Tablet by Prasco Laboratories
  • 66993-661 Raloxifene Hydrochloride 60 mg Oral Tablet, Film Coated by Prasco Laboratories
  • 8 more results ...

Other drugs which contain Raloxifene or a similar ingredient: (1 result)

Related Raloxifene Topics:

raloxifene HCL evista lilly sa
prevention osteoporosis ## medical prescriptio for preventio of osteoporosis post menopausia... 1 reply
raloxifene HCL
evista Lilly SA...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA